A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Indian astronaut Shubhanshu Shukla is part of a landmark ISS mission studying how diabetes behaves in space, aiming to make ...